The role of small-volume lymph node disease (ITC and micro metastases) among patients with endometrial or cervical cancer submitted to sentinel node (SLN) procedure is not clearly defined. This study was designed to create a dataset of patients with lymph nodal disease. Data on type and volume of lymph nodal disease, therapeutic choices and oncological outcomes (DFS, OS, recurrence rate) will be collected and analyzed. This will allow to define the groups of patients who may need or for whom it can be avoided any adjuvant treatment on the basis of lymph node status.
Study Type
OBSERVATIONAL
Enrollment
500
Evaluation of type and volume of lymph nodal disease
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
RECRUITINGSurvival (Disease free survival [DFS], overall survival [OS])
Evaluation of survival outcomes according to the type and volume of lymph nodal disease
Time frame: through study completion, an average of 3 years
Recurrence rate
Evaluation of incidence of recurrences (number of patients having a recurrence) according to the type and volume of lymph nodal disease
Time frame: through study completion, an average of 3 year
Usage of adjuvant therapy in case of small-volume lymph node disease
Evaluation of the number of patients receiving or not receiving an adjuvant treatment (radiation therapy, chemotherapy, combinations of the two) in case of small-volume lymph node disease (ITC and micro metastasis)
Time frame: through study completion, an average of 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.